The global non-opioid pain patches market is estimated to grow at a CAGR of nearly 4.5% during the forecast period. The rising incidences of neuropathic pain have led to the demand for non-opioid pain patches. Neuropathic pain condition is normally chronic, which is often caused by progressive, chronic, nerve disease, and can occur due to the injury or infection. Rising incidences of spinal cord injury and increasing prevalence of diabetes are some major causes of neuropathic pain. According to the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the incidence of spinal cord injury is nearly 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year.



Get Free Sample Copy @

https://www.omrglobal.com/request-sample/non-opioid-pain-patches-market



As of 2019, in the US, the estimated number of people with spinal cord injury is nearly 291,000. An estimated 78% of new incidences have witnessed among males. People suffering from spinal cord injury may suffer from several forms of pain which occurs in various areas of the body, such as neuropathic pain, musculoskeletal pain, and visceral pain. Spinal cord injury may result in damage to any part of the spine or nerve which causes abnormal communication between the nerves and this condition results in neuropathic pain. This contributes to the increasing demand for pain management techniques to reduce the amount of pain.



Browse for Full Report at:

https://www.omrglobal.com/industry-reports/non-opioid-pain-patches-market



Lidocaine patches are used to provide relief from pain occurs due to post-herpetic neuralgia. It works by stopping nerves from transmitting pain signals. Rising prevalence of diabetic patients is further leading the demand for neuropathic pain management. Nerve damage is more common in the diabetic population, which results in the increasing prevalence of diabetic neuropathy. Owing to the rising prevalence of diabetic neuropathy, the non-opioid patch manufacturers are launching new products for potential relief from pain.

For instance, in December 2019, Averitas Pharma, Inc. declared the supplemental New Drug Application (sNDA) for QUTENZA (capsaicin 8% patch) to treat neuropathic pain associated with diabetic peripheral neuropathy. This is a major step forward for the company towards the goal of getting QUTENZA FDA approved for diabetic peripheral neuropathy. There are millions of patients suffering from painful diabetic peripheral neuropathy and looking for effective pain relief. These novel pipeline products are expected to offer an opportunity for the growth of the global non-opioid pain patches market.



Global Non-Opioid Pain Patches Market- Segmentation

By Patch Type
Lidocaine Patches
Diclofenac Patches
Capsaicin Patches
Ketoprofen Patches
Others

By Distribution Channel
Hospitals
Online Pharmacies
Drug Stores


Global Non-Opioid Pain Patches Market– Segment by Region

North America
US
Canada

Europe
Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific
China
Japan
India
Rest of Asia-Pacific

Rest of the World



Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.




For More Customized Data, Request for Report Customization @

https://www.omrglobal.com/report-customization/non-opioid-pain-patches-market




About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404